Price Move History
- Daily moves over 5%
- 55 89 sessions, November 7, 2025 to November 9, 2026
- Largest daily move
- +1109900% close of June 18, 2026
- 1-year change
- -99% closing prices, November 7, 2025 to November 9, 2026
- 1-month change
- -93.3% closing prices, October 9, 2026 to November 9, 2026
Company Description
Panbela Therapeutics (OTC: PBLA) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $970.0.
PBLA declined 99.0% in the 12 months to November 9, 2026. The last closing price was $0.0002.
This page collects what Stock Titan holds for PBLA, including price data, latest news, and short interest trends.
Stock Performance
Panbela Therapeutics (PBLA) closed at $0.0002 on November 9, 2026. In the 12 months to November 9, 2026, the price lost 99.0%.
See what a $1,000 investment in PBLA was worth at its last close
PBLA Metrics & Rankings
Price returns through November 9, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Panbela Therapeutics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences, clinical trial. View all PBLA news →
SEC Filings
Short Interest History
Short interest in Panbela Therapeutics (PBLA) currently stands at 3 shares, representing 0.0% of the float.
Days to Cover History
Days to cover for Panbela Therapeutics (PBLA) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
PBLA Company Profile & Sector Positioning
Panbela Therapeutics (PBLA) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing PBLA often look at related companies in the same sector, including HAVN Life Sciences Inc (HAVLF), Evelo Biosciences Inc (EVLO), Innoveren Scientific Inc (IVRN), Core One Labs Inc (CLABF), and Trevena Inc (TRVN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PBLA's relative position within its industry.